A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 Cells in Subjects with Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Sponsor
Pluristem Ltd

Protocol Number
PLX-R18-HCT-01

To Learn More Call
201-510-0910